President Trump hints at reclassifying marijuana as a less dangerous drug, potentially shifting its status from Schedule 1 to Schedule 3. This decision could open doors for research and tax benefits for the cannabis industry.
In a surprising announcement, Trump revealed plans to reclassify marijuana from a Schedule I to a Schedule III drug, which could significantly impact the cannabis market and investor interest. Experts predict that this change could take about a year, but optimism in the industry is rising.
